I think the greater concern is that it’s hard to measure. And yes, you could imagine that owning shares against, say, the efficacy of a vaccine being above a certain level could be read as an incentive to sabotage the effort to develop it.
I think the greater concern is that it’s hard to measure. And yes, you could imagine that owning shares against, say, the efficacy of a vaccine being above a certain level could be read as an incentive to sabotage the effort to develop it.